West Virginia University Cancer Institute is West Virginia’s premier cancer facility with a national reputation of excellence in cancer treatment, prevention and research. The Scientific Programs within the MBRCC are organized to nurture interactions between basic, clinical and population scientists and are designed to impact on specific health disparities and populations with unique needs within our state.Read More
Timothy Eubank, PhD, associate professor in the WVU Department of Microbiology, Immunology & Cell Biology, has been invited to serve on the NIH Cancer Health Disparities/Diversity Review Panel that will meet March 30-31 in Rockville, Maryland. Panel members will review R21 applications aimed to enhance the diversity of the NCI-funded research workforce focusing on basic cancer research and cancer health disparities. Additionally, they will review R01 and R21 applications focusing on basic research studies into the biological/genetic causes and mechanisms of cancer health disparities. While at Ohio State and WVU, Dr. Eubank has served on internal study sections such as the OSU CCTS KL2 Career Development Program, CCTS Davis Bremer CCTS Pre-K award, OSU Comprehensive Cancer Center Intramural Research Basic Science Program, and the American Cancer Society Institutional Research Grant Study Sections. Nationally, he has reviewed grants for the Florida Department of Health Bankhead-Coley Cancer Research Program, and internationally for both Cancer Research, UK and MEDIC Foundation, Switzerland. Dr. Eubank is a member of the WVU Cancer Institute Breast Cancer Research Program.
Patrick Thomas, a WVU Cancer Institute undergraduate cancer researcher, has been selected to present his work at the 14th Annual Undergraduate Research Day at the Capitol in Charleston on February 24. The title of the poster he will share with lawmakers is The Bone Marrow Microenvironment Causes Metabolic Changes in Acute Lymphoblastic Leukemia. This research outlines how ALL tumor populations that enter the bone marrow microenvironment and become resistant to chemotherapy have an elevated glucose metabolism, and proposes tactics for sensitizing this population.